Amgen Inc. Comprehensive Income
Amgen Inc. (AMGN) reported Comprehensive Income of $2.45 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-05
- Amgen Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was $2.45B, a 118.59% increase year-over-year.
- Amgen Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was $1.89B, a 20.58% increase year-over-year.
- Amgen Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $1.50B, a 66.89% increase year-over-year.
- Amgen Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was $3.34B, a 26.01% increase year-over-year.
- Amgen Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was $7.52B, a 74.33% increase from fiscal 2024.
- Amgen Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was $4.31B, a 35.23% decline from fiscal 2023.
- Amgen Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was $6.66B, a 6.44% decline from fiscal 2022.
- Amgen Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was $7.12B, a 17.02% increase from fiscal 2021.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $2.45B 10-Q · filed 2026-08-05 | $4.33B 10-Q · filed 2026-08-05 | $5.83B derived: sum of 3 quarters · filed 2026-08-05 | $9.17B derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $1.89B 10-Q · filed 2026-05-01 | $3.38B derived: sum of 2 quarters · filed 2026-05-01 | $6.72B derived: sum of 3 quarters · filed 2026-05-01 | $7.84B derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $1.50B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $4.83B derived: sum of 2 quarters · filed 2026-02-13 | $5.95B derived: sum of 3 quarters · filed 2026-08-05 | $7.52B 10-K · filed 2026-02-13 | |
| 2025-09-30 | $3.34B 10-Q · filed 2025-11-05 | $4.46B derived: sum of 2 quarters · filed 2026-08-05 | $6.02B 10-Q · filed 2025-11-05 | $6.92B derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $1.12B 10-Q · filed 2026-08-05 | $2.68B 10-Q · filed 2026-08-05 | $3.58B derived: sum of 3 quarters · filed 2026-08-05 | $6.23B derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $1.56B 10-Q · filed 2026-05-01 | $2.46B derived: sum of 2 quarters · filed 2026-05-01 | $5.11B derived: sum of 3 quarters · filed 2026-05-01 | $5.89B derived: sum of 4 quarters · filed 2026-05-01 | |
| 2024-12-31 | $897.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $3.55B derived: sum of 2 quarters · filed 2026-02-13 | $4.33B derived: sum of 3 quarters · filed 2026-02-13 | $4.31B 10-K · filed 2026-02-13 | |
| 2024-09-30 | $2.65B 10-Q · filed 2025-11-05 | $3.43B derived: sum of 2 quarters · filed 2025-11-05 | $3.42B 10-Q · filed 2025-11-05 | $4.02B derived: sum of 4 quarters · filed 2026-02-13 | |
| 2024-06-30 | $781.00M 10-Q · filed 2025-08-06 | $767.00M 10-Q · filed 2025-08-06 | $1.37B derived: sum of 3 quarters · filed 2026-02-13 | $3.25B derived: sum of 4 quarters · filed 2026-02-13 | |
| 2024-03-31 | -$14.00M 10-Q · filed 2025-05-02 | $590.00M derived: sum of 2 quarters · filed 2026-02-13 | $2.47B derived: sum of 3 quarters · filed 2026-02-13 | $3.84B derived: sum of 4 quarters · filed 2026-02-13 | |
| 2023-12-31 | $604.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $2.49B derived: sum of 2 quarters · filed 2026-02-13 | $3.85B derived: sum of 3 quarters · filed 2026-02-13 | $6.66B 10-K · filed 2026-02-13 | |
| 2023-09-30 | $1.88B 10-Q · filed 2024-10-31 | $3.25B derived: sum of 2 quarters · filed 2024-10-31 | $6.05B 10-Q · filed 2024-10-31 | $8.09B derived: sum of 4 quarters · filed 2025-02-14 | |
| 2023-06-30 | $1.37B 10-Q · filed 2024-08-07 | $4.17B 10-Q · filed 2024-08-07 | $6.21B derived: sum of 3 quarters · filed 2025-02-14 | $8.37B derived: sum of 4 quarters · filed 2025-02-14 | |
| 2023-03-31 | $2.80B 10-Q · filed 2024-05-03 | $4.84B derived: sum of 2 quarters · filed 2025-02-14 | $7.00B derived: sum of 3 quarters · filed 2025-02-14 | $8.41B derived: sum of 4 quarters · filed 2025-02-14 | |
| 2022-12-31 | $2.04B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $4.20B derived: sum of 2 quarters · filed 2025-02-14 | $5.61B derived: sum of 3 quarters · filed 2025-02-14 | $7.12B 10-K · filed 2025-02-14 | |
| 2022-09-30 | $2.16B 10-Q · filed 2023-10-31 | $3.57B derived: sum of 2 quarters · filed 2023-10-31 | $5.08B 10-Q · filed 2023-10-31 | $6.99B derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-06-30 | $1.41B 10-Q · filed 2023-08-04 | $2.92B 10-Q · filed 2023-08-04 | $4.83B derived: sum of 3 quarters · filed 2024-02-14 | $6.77B derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-03-31 | $1.51B 10-Q · filed 2023-04-28 | $3.42B derived: sum of 2 quarters · filed 2024-02-14 | $5.36B derived: sum of 3 quarters · filed 2024-02-14 | $5.79B derived: sum of 4 quarters · filed 2024-02-14 | |
| 2021-12-31 | $1.91B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $3.85B derived: sum of 2 quarters · filed 2024-02-14 | $4.28B derived: sum of 3 quarters · filed 2024-02-14 | $6.08B 10-K · filed 2024-02-14 | |
| 2021-09-30 | $1.94B 10-Q · filed 2022-11-04 | $2.37B derived: sum of 2 quarters · filed 2022-11-04 | $4.17B 10-Q · filed 2022-11-04 | $5.70B derived: sum of 4 quarters · filed 2023-02-09 | |
| 2021-06-30 | $429.00M 10-Q · filed 2022-08-05 | $2.23B 10-Q · filed 2022-08-05 | $3.76B derived: sum of 3 quarters · filed 2023-02-09 | $5.66B derived: sum of 4 quarters · filed 2023-02-09 | |
| 2021-03-31 | $1.80B 10-Q · filed 2022-04-28 | $3.33B derived: sum of 2 quarters · filed 2023-02-09 | $5.23B derived: sum of 3 quarters · filed 2023-02-09 | $6.91B derived: sum of 4 quarters · filed 2023-02-09 | |
| 2020-12-31 | $1.53B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $3.43B derived: sum of 2 quarters · filed 2023-02-09 | $5.12B derived: sum of 3 quarters · filed 2023-02-09 | $6.81B 10-K · filed 2023-02-09 | |
| 2020-09-30 | $1.90B 10-Q · filed 2021-11-03 | $3.58B derived: sum of 2 quarters · filed 2021-11-03 | $5.27B 10-Q · filed 2021-11-03 | $6.84B derived: sum of 4 quarters · filed 2022-02-16 | |
| 2020-06-30 | $1.68B 10-Q · filed 2021-08-04 | $3.37B 10-Q · filed 2021-08-04 | $4.94B derived: sum of 3 quarters · filed 2022-02-16 | $6.98B derived: sum of 4 quarters · filed 2022-02-16 | |
| 2020-03-31 | $1.69B 10-Q · filed 2021-04-28 | $3.25B derived: sum of 2 quarters · filed 2022-02-16 | $5.30B derived: sum of 3 quarters · filed 2022-02-16 | $7.53B derived: sum of 4 quarters · filed 2022-02-16 | |
| 2019-12-31 | $1.56B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $3.61B derived: sum of 2 quarters · filed 2022-02-16 | $5.84B derived: sum of 3 quarters · filed 2022-02-16 | $8.08B 10-K · filed 2022-02-16 | |
| 2019-09-30 | $2.04B 10-Q · filed 2020-10-29 | $4.28B derived: sum of 2 quarters · filed 2020-10-29 | $6.52B 10-Q · filed 2020-10-29 | $8.49B derived: sum of 4 quarters · filed 2021-02-09 | |
| 2019-06-30 | $2.23B 10-Q · filed 2020-07-29 | $4.47B 10-Q · filed 2020-07-29 | $6.44B derived: sum of 3 quarters · filed 2021-02-09 | $8.37B derived: sum of 4 quarters · filed 2021-02-09 | |
| 2019-03-31 | $2.25B 10-Q · filed 2020-05-01 | $4.21B derived: sum of 2 quarters · filed 2021-02-09 | $6.14B derived: sum of 3 quarters · filed 2021-02-09 | $8.55B derived: sum of 4 quarters · filed 2021-02-09 | |
| 2018-12-31 | $1.97B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $3.89B derived: sum of 2 quarters · filed 2021-02-09 | $6.31B derived: sum of 3 quarters · filed 2021-02-09 | $8.31B 10-K · filed 2021-02-09 | |
| 2018-09-30 | $1.92B 10-Q · filed 2019-10-30 | $4.34B derived: sum of 2 quarters · filed 2019-10-30 | $6.34B 10-Q · filed 2019-10-30 | $1.84B derived: sum of 4 quarters · filed 2020-02-12 | |
| 2018-06-30 | $2.42B 10-Q · filed 2019-07-31 | $4.42B 10-Q · filed 2019-07-31 | -$78.00M derived: sum of 3 quarters · filed 2020-02-12 | $1.95B derived: sum of 4 quarters · filed 2020-02-12 | |
| 2018-03-31 | $2.00B 10-Q · filed 2019-05-01 | $2.00B 10-Q · filed 2018-04-25 | -$2.50B derived: sum of 2 quarters · filed 2020-02-12 | -$468.00M derived: sum of 3 quarters · filed 2020-02-12 | $1.60B derived: sum of 4 quarters · filed 2020-02-12 |
| 2017-12-31 | -$4.50B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | -$2.47B derived: sum of 2 quarters · filed 2020-02-12 | -$409.00M derived: sum of 3 quarters · filed 2020-02-12 | $1.77B 10-K · filed 2020-02-12 | |
| 2017-09-30 | $2.03B 10-Q · filed 2018-10-31 | $4.09B derived: sum of 2 quarters · filed 2018-10-31 | $6.27B 10-Q · filed 2018-10-31 | $7.87B derived: sum of 4 quarters · filed 2019-02-13 | |
| 2017-06-30 | $2.06B 10-Q · filed 2018-07-27 | $4.24B 10-Q · filed 2018-07-27 | $5.85B derived: sum of 3 quarters · filed 2019-02-13 | $7.83B derived: sum of 4 quarters · filed 2019-02-13 | |
| 2017-03-31 | $2.18B 10-Q · filed 2018-04-25 | $3.78B derived: sum of 2 quarters · filed 2019-02-13 | $5.77B derived: sum of 3 quarters · filed 2019-02-13 | $7.80B derived: sum of 4 quarters · filed 2019-02-13 | |
| 2016-12-31 | $1.60B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $3.59B derived: sum of 2 quarters · filed 2019-02-13 | $5.62B derived: sum of 3 quarters · filed 2019-02-13 | $7.73B 10-K · filed 2019-02-13 | |
| 2016-09-30 | $1.98B 10-Q · filed 2017-10-26 | $4.02B derived: sum of 2 quarters · filed 2017-10-26 | $6.13B 10-Q · filed 2017-10-26 | $7.68B derived: sum of 4 quarters · filed 2018-02-13 | |
| 2016-06-30 | $2.03B 10-Q · filed 2017-07-26 | $4.14B 10-Q · filed 2017-07-26 | $5.70B derived: sum of 3 quarters · filed 2018-02-13 | $7.39B derived: sum of 4 quarters · filed 2018-02-13 | |
| 2016-03-31 | $2.11B 10-Q · filed 2017-04-27 | $3.67B derived: sum of 2 quarters · filed 2018-02-13 | $5.36B derived: sum of 3 quarters · filed 2018-02-13 | $6.81B derived: sum of 4 quarters · filed 2018-02-13 | |
| 2015-12-31 | $1.56B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $3.25B derived: sum of 2 quarters · filed 2018-02-13 | $4.70B derived: sum of 3 quarters · filed 2018-02-13 | $6.47B 10-K · filed 2018-02-13 | |
| 2015-09-30 | $1.69B 10-Q · filed 2016-10-28 | $3.14B derived: sum of 2 quarters · filed 2016-10-28 | $4.91B 10-Q · filed 2016-10-28 | $6.30B derived: sum of 4 quarters · filed 2017-02-14 | |
| 2015-06-30 | $1.45B 10-Q · filed 2016-07-29 | $3.22B 10-Q · filed 2016-07-29 | $4.61B derived: sum of 3 quarters · filed 2017-02-14 | $5.87B derived: sum of 4 quarters · filed 2017-02-14 | |
| 2015-03-31 | $1.77B 10-Q · filed 2016-05-02 | $3.16B derived: sum of 2 quarters · filed 2017-02-14 | $4.42B derived: sum of 3 quarters · filed 2017-02-14 | $5.97B derived: sum of 4 quarters · filed 2017-02-14 | |
| 2014-12-31 | $1.39B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $2.65B derived: sum of 2 quarters · filed 2017-02-14 | $4.20B derived: sum of 3 quarters · filed 2017-02-14 | $5.31B 10-K · filed 2017-02-14 | |
| 2014-09-30 | $1.26B 10-Q · filed 2015-11-02 | $2.81B derived: sum of 2 quarters · filed 2015-11-02 | $3.92B 10-Q · filed 2015-11-02 | $4.88B derived: sum of 4 quarters · filed 2016-10-31 | |
| 2014-06-30 | $1.55B 10-Q · filed 2015-08-05 | $2.66B 10-Q · filed 2015-08-05 | $3.62B derived: sum of 3 quarters · filed 2016-10-31 | $4.96B derived: sum of 4 quarters · filed 2016-10-31 | |
| 2014-03-31 | $1.11B 10-Q · filed 2015-04-27 | $2.06B derived: sum of 2 quarters · filed 2016-10-31 | $3.41B derived: sum of 3 quarters · filed 2016-10-31 | $4.46B derived: sum of 4 quarters · filed 2016-10-31 | |
| 2013-12-31 | $957.00M derived: 8-K 12 month − 10-Q 9 month · filed 2016-10-31 | $2.30B derived: sum of 2 quarters · filed 2016-10-31 | $3.35B derived: sum of 3 quarters · filed 2016-10-31 | $4.77B 8-K · filed 2016-10-31 | |
| 2013-09-30 | $1.34B 10-Q · filed 2014-10-29 | $2.39B derived: sum of 2 quarters · filed 2014-10-29 | $3.82B 10-Q · filed 2014-10-29 | $4.60B derived: sum of 4 quarters · filed 2015-02-19 | |
| 2013-06-30 | $1.05B 10-Q · filed 2014-08-05 | $2.48B 10-Q · filed 2014-08-05 | $3.26B derived: sum of 3 quarters · filed 2015-02-19 | $4.37B derived: sum of 4 quarters · filed 2015-02-19 | |
| 2013-03-31 | $1.43B 10-Q · filed 2014-04-30 | $2.21B derived: sum of 2 quarters · filed 2015-02-19 | $3.31B derived: sum of 3 quarters · filed 2015-02-19 | $4.63B derived: sum of 4 quarters · filed 2015-02-19 | |
| 2012-12-31 | $787.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19 | $1.89B derived: sum of 2 quarters · filed 2015-02-19 | $3.20B derived: sum of 3 quarters · filed 2015-02-19 | $4.32B 10-K · filed 2015-02-19 | |
| 2012-09-30 | $1.10B 10-Q · filed 2013-10-29 | $2.41B derived: sum of 2 quarters · filed 2013-10-29 | $3.53B 10-Q · filed 2013-10-29 | $4.52B derived: sum of 4 quarters · filed 2014-02-24 | |
| 2012-06-30 | $1.31B 10-Q · filed 2013-08-06 | $2.43B 10-Q · filed 2013-08-06 | $3.42B derived: sum of 3 quarters · filed 2014-02-24 | $3.94B derived: sum of 4 quarters · filed 2014-02-24 | |
| 2012-03-31 | $1.12B 10-Q · filed 2013-05-03 | $2.11B derived: sum of 2 quarters · filed 2014-02-24 | $2.63B derived: sum of 3 quarters · filed 2014-02-24 | $3.86B derived: sum of 4 quarters · filed 2014-02-24 | |
| 2011-12-31 | $987.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $1.51B derived: sum of 2 quarters · filed 2014-02-24 | $2.74B derived: sum of 3 quarters · filed 2014-02-24 | $3.70B 10-K · filed 2014-02-24 | |
| 2011-09-30 | $527.00M 10-Q · filed 2012-11-06 | $1.75B derived: sum of 2 quarters · filed 2012-11-06 | $2.71B 10-Q · filed 2012-11-06 | ||
| 2011-06-30 | $1.22B 10-Q · filed 2012-08-08 | $2.19B 10-Q · filed 2012-08-08 | |||
| 2011-03-31 | $963.00M 10-Q · filed 2012-05-08 | ||||
| 2010-12-31 | $4.74B 10-K · filed 2013-02-27 | ||||
| 2009-12-31 | $4.53B 10-K · filed 2012-02-29 | ||||
| 2008-12-31 | $4.12B 10-K · filed 2011-02-25 | ||||
| 2007-12-31 | $3.12B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |